Exposure to Bisphenol A and Bisphenol S and Incident Type 2 Diabetes: A Case-Cohort Study in the French Cohort D.E.S.I.R

Overview

Journal Environ Health Perspect

Date 2019 Oct 31

PMID 31663775

Citations 37

Authors

Fanny Ranciere

Jeremie Botton

Remy Slama

Marlene Z Lacroix

Laurent Debrauwer

Marie Aline Charles

Ronan Roussel

Beverley Balkau

Dianna J Magliano

Affiliations

Soon will be listed here.

Abstract

Background: The question of whether exposure to bisphenol A (BPA) contributes to the development of type 2 diabetes is still unresolved. Most epidemiological evidence on the association between BPA and diabetes is from cross-sectional studies or longitudinal studies with single urinary measurements. No prospective study has examined exposure to BPA analogs such as bisphenol S (BPS) in relation to incident type 2 diabetes.

Objectives: We aimed to investigate whether exposure to BPA and BPS, assessed at up to two time points, was associated with the incidence of type 2 diabetes.

Methods: We performed a case-cohort study on 755 participants without diabetes at baseline and followed-up over 9 y as part of the French prospective cohort Data from an Epidemiological Study on the Insulin Resistance Syndrome (D.E.S.I.R.). BPA-glucuronide (BPA-G) and BPS-glucuronide (BPS-G) were assessed in fasting spot urine samples collected during the health examinations at baseline and 3 y later. Associations with incident diabetes were examined using Prentice-weighted Cox regression models adjusted for potential confounders.

Results: A total of 201 incident cases of type 2 diabetes were diagnosed over the follow-up, including 30 in the subcohort. Compared with participants with the lowest average BPA exposure (below the first quartile), participants in the second, third, and fourth quartile groups of exposure had a near doubling of the risk of type 2 diabetes, with a hazard ratio 2.56 (95% CI: 1.16, 5.65), 2.35 (95% CI: 1.07, 5.15), and 1.56 (95% CI: 0.68, 3.55), respectively. The detection of BPS-G in urine at one or both time points was associated with incident diabetes, with an 2.81 (95% CI: 1.74, 4.53).

Discussion: This study shows positive associations between exposure to BPA and BPS and the incidence of type 2 diabetes, independent of traditional diabetes risk factors. Our results should be confirmed by recent, population-based observational studies in different populations and settings. Overall, these findings raise concerns about using BPS as a BPA substitute. Further research on BPA analogs is warranted. https://doi.org/10.1289/EHP5159.

Citing Articles

as a Model to Assess the Potential Risk to Human Health Associated with the Use of Bisphenol A and Its Substitutes.

Kaiglova A, Bardyova Z, Hockickova P, Zvolenska A, Melnikov K, Kucharikova S Int J Mol Sci. 2025; 26(5).

PMID: 40076635 PMC: 11900329. DOI: 10.3390/ijms26052013.

Temporal and geographic variability of bisphenol levels in humans: A systematic review and meta-analysis of international biomonitoring data.

Acevedo J, Kahn L, Pierce K, Carrasco A, Singer Rosenberg M, Trasande L Environ Res. 2024; 264(Pt 1):120341.

PMID: 39522874 PMC: 11863187. DOI: 10.1016/j.envres.2024.120341.

Associations between antimony exposure and glycated hemoglobin levels in adolescents aged 12-19 years: results from the NHANES 2013-2016.

Feng B, Tang P, He S, Peng Z, Mo Y, Zhu L Front Public Health. 2024; 12:1439034.

PMID: 39484344 PMC: 11524935. DOI: 10.3389/fpubh.2024.1439034.

The Adverse Impact of Bisphenol A Exposure on Optimal Cardiovascular Health as Measured by Life's Essential 8 in U.S. Adults: Evidence from NHANES 2005 to 2016.

Chen Y, Xu C, Huang Y, Liu Z, Zou J, Zhu H Nutrients. 2024; 16(19).

PMID: 39408220 PMC: 11478777. DOI: 10.3390/nu16193253.

Environmental endocrine disruptor-induced mitochondrial dysfunction: a potential mechanism underlying diabetes and its complications.

He K, Chen R, Xu S, Ding Y, Wu Z, Bao M Front Endocrinol (Lausanne). 2024; 15:1422752.

PMID: 39211449 PMC: 11357934. DOI: 10.3389/fendo.2024.1422752.

References

Stahlhut R, Welshons W, Swan S . Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ Health Perspect. 2009; 117(5):784-9. PMC: 2685842. DOI: 10.1289/ehp.0800376. View

Ranciere F, Lyons J, Loh V, Botton J, Galloway T, Wang T . Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence. Environ Health. 2015; 14:46. PMC: 4472611. DOI: 10.1186/s12940-015-0036-5. View

Nepomnaschy P, Baird D, Weinberg C, Hoppin J, Longnecker M, Wilcox A . Within-person variability in urinary bisphenol A concentrations: measurements from specimens after long-term frozen storage. Environ Res. 2009; 109(6):734-7. PMC: 2810154. DOI: 10.1016/j.envres.2009.04.004. View

Ye X, Wong L, Bishop A, Calafat A . Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-hour collections. Environ Health Perspect. 2011; 119(7):983-8. PMC: 3223007. DOI: 10.1289/ehp.1002701. View

Volkel W, Colnot T, Csanady G, Filser J, Dekant W . Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem Res Toxicol. 2002; 15(10):1281-7. DOI: 10.1021/tx025548t. View

Liao C, Liu F, Alomirah H, Loi V, Ali Mohd M, Moon H . Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 2012; 46(12):6860-6. DOI: 10.1021/es301334j. View

Alonso-Magdalena P, Quesada I, Nadal A . Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol. 2011; 7(6):346-53. DOI: 10.1038/nrendo.2011.56. View

Barlow W, Ichikawa L, ROSNER D, Izumi S . Analysis of case-cohort designs. J Clin Epidemiol. 1999; 52(12):1165-72. DOI: 10.1016/s0895-4356(99)00102-x. View

Lee D, Porta M, Jacobs Jr D, Vandenberg L . Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev. 2014; 35(4):557-601. PMC: 5393257. DOI: 10.1210/er.2013-1084. View

10.

Teeguarden J, Calafat A, Ye X, Doerge D, Churchwell M, Gunawan R . Twenty-four hour human urine and serum profiles of bisphenol a during high-dietary exposure. Toxicol Sci. 2011; 123(1):48-57. DOI: 10.1093/toxsci/kfr160. View

11.

Wu L, Zhang X, Wang F, Gao C, Chen D, Palumbo J . Occurrence of bisphenol S in the environment and implications for human exposure: A short review. Sci Total Environ. 2017; 615:87-98. DOI: 10.1016/j.scitotenv.2017.09.194. View

12.

Townsend M, Franke A, Li X, Hu F, Eliassen A . Within-person reproducibility of urinary bisphenol A and phthalate metabolites over a 1 to 3 year period among women in the Nurses' Health Studies: a prospective cohort study. Environ Health. 2013; 12(1):80. PMC: 3847616. DOI: 10.1186/1476-069X-12-80. View

13.

Hectors T, Vanparys C, van der Ven K, Martens G, Jorens P, Van Gaal L . Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia. 2011; 54(6):1273-90. DOI: 10.1007/s00125-011-2109-5. View

14.

Liao C, Kannan K . Determination of free and conjugated forms of bisphenol A in human urine and serum by liquid chromatography-tandem mass spectrometry. Environ Sci Technol. 2012; 46(9):5003-9. DOI: 10.1021/es300115a. View

15.

Li A, Xue J, Lin S, Al-Malki A, Al-Ghamdi M, Kumosani T . Urinary concentrations of environmental phenols and their association with type 2 diabetes in a population in Jeddah, Saudi Arabia. Environ Res. 2018; 166:544-552. DOI: 10.1016/j.envres.2018.06.040. View

16.

Magliano D, Lyons J . Bisphenol A and diabetes, insulin resistance, cardiovascular disease and obesity: controversy in a (plastic) cup?. J Clin Endocrinol Metab. 2012; 98(2):502-4. DOI: 10.1210/jc.2012-3058. View

17.

Barr D, Wilder L, Caudill S, Gonzalez A, Needham L, Pirkle J . Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 2005; 113(2):192-200. PMC: 1277864. DOI: 10.1289/ehp.7337. View

18.

Perrier F, Giorgis-Allemand L, Slama R, Philippat C . Within-subject Pooling of Biological Samples to Reduce Exposure Misclassification in Biomarker-based Studies. Epidemiology. 2016; 27(3):378-88. PMC: 4820663. DOI: 10.1097/EDE.0000000000000460. View

19.

Chen D, Kannan K, Tan H, Zheng Z, Feng Y, Wu Y . Bisphenol Analogues Other Than BPA: Environmental Occurrence, Human Exposure, and Toxicity-A Review. Environ Sci Technol. 2016; 50(11):5438-53. DOI: 10.1021/acs.est.5b05387. View

20.

Chatterjee S, Khunti K, Davies M . Type 2 diabetes. Lancet. 2017; 389(10085):2239-2251. DOI: 10.1016/S0140-6736(17)30058-2. View